{'fraction_non_alphanumeric': 0.05593607305936073, 'fraction_numerical': 0.02968036529680365, 'mean_word_length': 4.283132530120482, 'pattern_counts': {'":': 0, '<': 1, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Dynamic monitoring of serum soluble HLA class I antigens in renal transplant recipients].

OBJECTIVE
To investigate the relations between serum soluble HLA class I antigens (sHLA-I) and the period of acute rejection and infection in renal transplant recipients.


METHODS
We measured the serum levels of sHLA-I in 36 renal transplant recipients with ELISA dynamically.


RESULTS
The serum sHAL-I levels were higher in uremia patients than in normal controls [(2.94 +/- 0.34) microg/L vs. (0.76 +/- 0.33) microg/L, P < 0.05]. After renal transplantation, the serum sHLA-I levels decreased significantly in stable patients [(0.63 +/- 0.33) microg/L], but increased significantly 3 days before acute rejection and 5 or 7 days after infection.


CONCLUSIONS
The serum sHLA-I levels can be used as a parameter for monitoring acute rejection and infection in renal transplantation.